DESENVOLVIMENTO E AVALIAÇÃO DE MICROPARTÍCULAS POLIMÉRICAS CONTENDO CAPSAICINOIDES
Capsaicinoids show several therapeutic uses. However they cause pungency in contact with skin and mucosae. In that sense, the aim of this study was to obtain microparticles of poly (-caprolactone) (PCL) containing capsaicinoids for prolonged release through the gastrointestinal tract in order to imp...
| Autor: | |
|---|---|
| Tipo de recurso: | tesis de maestría |
| Estado: | Versión publicada |
| Fecha de publicación: | 2013 |
| País: | Brasil |
| Institución: | Universidade Estadual de Ponta Grossa (UEPG) |
| Repositorio: | Biblioteca Digital de Teses e Dissertações da UEPG |
| Idioma: | portugués |
| OAI Identifier: | oai:tede2.uepg.br:prefix/109 |
| Acceso en línea: | http://tede2.uepg.br/jspui/handle/prefix/109 |
| Access Level: | acceso abierto |
| Palabra clave: | Capsaicina Di-hidrocapsaicina liberação controlada micropartículas obesidade Capsaicin controlled release dihydrocapsaicin microparticles obesity CNPQ::CIENCIAS DA SAUDE::FARMACIA |
| Sumario: | Capsaicinoids show several therapeutic uses. However they cause pungency in contact with skin and mucosae. In that sense, the aim of this study was to obtain microparticles of poly (-caprolactone) (PCL) containing capsaicinoids for prolonged release through the gastrointestinal tract in order to improve the treatment of obesity. Formulations containing 3, 5 and 10% capsaicinoids were successfully prepared by simple emulsion/solvent evaporation. Values of encapsulation efficiency above 90% were observed for these vanillylamide-loaded microparticles. Microparticles showed spherical shape and smooth surface. The size was suitable for oral use in order to provide a release through the gastrointestinal tract. No chemical bonds were observed between drug and polymer. Microencapsulation led to drug amorphization. Formulations prolonged the release of capsaicinoids without changing the release kinetics (biexponential model). Microencapsulation increased the gastric tolerability of capsaicin and dihydrocapsaicin because it prevented inflammatory processes in the stomach of rats. Microparticles containing 5% capsaicinoids had an effect similar to ranitidine and omeprazole in preventing ulcerative lesions induced by ethanol. This same formulation demonstrated a statistically significant reduction of Lee index, mesenteric fat and retroperitoneal fat in rats with obesity induced by hypothalamic lesion using monosodium L-glutamate. These rats also showed a remarkable improvement in lipid profile and glucose level compared to the control groups. Based on the experimental results, it is possible to suggest that capsaicinoids-loaded PCL microparticles are feasible approaches for the treatment of obesity. |
|---|